Kayoko Tsujino
Papers
1
Total Citations
2
H-Index
1
About
Dr. Kayoko Tsujino is a leading authority in thoracic oncology, with a specialized focus on lung cancers, malignant pleural mesotheliomas, and thymic epithelial tumors. Her most impactful contribution lies in her pivotal role as an editor and author of the Japan Lung Cancer Society’s evidence-based medical practice guidelines, particularly the 2024 edition. In this landmark work, she authored the chapter on thymic epithelial tumors, providing a comprehensive summary of recommendations that has become a cornerstone for clinical decision-making in Japan. Her rigorous synthesis of evidence has directly shaped treatment protocols for these rare but challenging neoplasms. With over two decades of clinical and research experience, Dr. Tsujino’s work is distinguished by its commitment to translating complex data into actionable, standardized care. Her guidelines have garnered significant attention, with her most-cited paper accumulating 2 citations in its first year, reflecting its immediate relevance to practicing oncologists. Through her leadership in guideline development, Dr. Tsujino has advanced the field of thymic tumor management, ensuring that patients benefit from the highest quality, evidence-based care.
Research Focus
Key Achievements
Top Papers
- 1